Growing the growth cone: Remodeling the cytoskeleton to promote axon regeneration

Trends in Neurosciences

Volumn 35, Issue 3, 2012, Pages 164-174

  Hur, Eun Mi ^a   Saijilafu, ^a   Zhou, Feng Quan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; ACTIN; BINDING PROTEIN; BLEBBISTATIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DIACETYL OXIME; GLYCOGEN SYNTHASE KINASE 3; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 6; ISPINESIB; KINESIN 5; LITHIUM; MICROTUBULE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONASTROL; MYOSIN II; PACLITAXEL; PROTEOCHONDROITIN SULFATE; SIRTUIN 2; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR; TUBACIN; TUBULIN;

ACTIN FILAMENT; BINDING AFFINITY; BRAIN FUNCTION; CELL ACTIVITY; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CHEMICAL MODIFICATION; DEACYLATION; ENZYME INHIBITION; GENETIC SCREENING; GROWTH CONE; HISTONE ACETYLATION; HUMAN; INTRACELLULAR SPACE; MICROTUBULE; MOLECULAR DYNAMICS; MOLECULARLY TARGETED THERAPY; NERVE BLOCK; NERVE FIBER; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVOUS SYSTEM INJURY; NEURITE; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ACTINS; ANIMALS; AXONS; CYTOSKELETON; GROWTH CONES; HUMANS; MICROTUBULES; NERVE REGENERATION;

EID: 84857689488     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2011.11.002     Document Type: Review

References (117)

1. Filbin M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 2003, 4:703-713.
2. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
3. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-627.
4. Atwal J.K., et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008, 322:967-970.
5. Shen Y., et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
6. Cafferty W.B., et al. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J. Neurosci. 2010, 30:6825-6837.
7. Kim J.E., et al. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004, 44:439-451.
8. Silver J. Much ado about Nogo. Neuron 2010, 66:619-621.
9. Lee J.K., et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010, 66:663-670.
10. Nakamura Y., et al. Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury. J. Biol. Chem. 2011, 286:1876-1883.
11. Steward O., et al. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp. Neurol. 2008, 209:446-468.
12. Zheng B., et al. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1205-1210.
13. Moore D.L., et al. KLF family members regulate intrinsic axon regeneration ability. Science 2009, 326:298-301.
14. Raivich G., et al. The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 2004, 43:57-67.
15. Seijffers R., et al. ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration. J. Neurosci. 2007, 27:7911-7920.
16. Zou H., et al. Axotomy-induced Smad1 activation promotes axonal growth in adult sensory neurons. J. Neurosci. 2009, 29:7116-7123.
17. Liu K., et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 2010, 13:1075-1081.
18. Park K.K., et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008, 322:963-966.
19. Conde C., Caceres A. Microtubule assembly, organization and dynamics in axons and dendrites. Nat. Rev. Neurosci. 2009, 10:319-332.
20. Dent E.W., Gertler F.B. Cytoskeletal dynamics and transport in growth cone motility and axon guidance. Neuron 2003, 40:209-227.
21. Tanaka E., et al. The role of microtubule dynamics in growth cone motility and axonal growth. J. Cell Biol. 1995, 128:139-155.
22. Tanaka E.M., Kirschner M.W. Microtubule behavior in the growth cones of living neurons during axon elongation. J. Cell Biol. 1991, 115:345-363.
23. Erturk A., et al. Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration. J. Neurosci. 2007, 27:9169-9180.
24. Hur E.M., et al. Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5057-5062.
25. Hellal F., et al. Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science 2011, 331:928-931.
26. Sengottuvel V., et al. Taxol facilitates axon regeneration in the mature CNS. J. Neurosci. 2011, 31:2688-2699.
27. Jordan M.A., Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 2004, 4:253-265.
28. Dumontet C., Jordan M.A. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Discov. 2010, 9:790-803.
29. Hur E.M., Zhou F.Q. GSK3 signalling in neural development. Nat. Rev. Neurosci. 2010, 11:539-551.
30. Zhou F.Q., Snider W.D. Cell biology. GSK-3beta and microtubule assembly in axons. Science 2005, 308:211-214.
31. Dill J., et al. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J. Neurosci. 2008, 28:8914-8928.
32. Yoshimura T., et al. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005, 120:137-149.
33. Fukata Y., et al. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 2002, 4:583-591.
34. Suzuki Y., et al. Collapsin response mediator protein-2 accelerates axon regeneration of nerve-injured motor neurons of rat. J. Neurochem. 2003, 86:1042-1050.
35. Takei Y., et al. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J. Cell Biol. 2000, 150:989-1000.
36. Cavalli V., et al. Sunday driver links axonal transport to damage signaling. J. Cell Biol. 2005, 168:775-787.
37. Barnat M., et al. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration. J. Neurosci. 2010, 30:7804-7816.
38. Lindwall C., Kanje M. Retrograde axonal transport of JNK signaling molecules influence injury induced nuclear changes in p-c-Jun and ATF3 in adult rat sensory neurons. Mol. Cell. Neurosci. 2005, 29:269-282.
39. Chang L., et al. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev. Cell 2003, 4:521-533.
40. Gdalyahu A., et al. DCX, a new mediator of the JNK pathway. EMBO J. 2004, 23:823-832.
41. Goedert M., et al. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 1997, 409:57-62.
42. Reynolds C.H., et al. Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J. Neurochem. 1997, 68:1736-1744.
43. Tararuk T., et al. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J. Cell Biol. 2006, 173:265-277.
44. Mason M.R., et al. Transcriptional upregulation of SCG10 and CAP-23 is correlated with regeneration of the axons of peripheral and central neurons in vivo. Mol. Cell. Neurosci. 2002, 20:595-615.
45. Voria I., et al. Improved sciatic nerve regeneration by local thyroid hormone treatment in adult rat is accompanied by increased expression of SCG10. Exp. Neurol. 2006, 197:258-267.
46. Hammarlund M., et al. Axon regeneration requires a conserved MAP kinase pathway. Science 2009, 323:802-806.
47. Yan D., et al. The DLK-1 kinase promotes mRNA stability and local translation in C. elegans synapses and axon regeneration. Cell 2009, 138:1005-1018.
48. Nix P., et al. Axon regeneration requires coordinate activation of p38 and JNK MAPK pathways. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10738-10743.
49. Lewcock J.W., et al. The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. Neuron 2007, 56:604-620.
50. Collins C.A., et al. Highwire restrains synaptic growth by attenuating a MAP kinase signal. Neuron 2006, 51:57-69.
51. Nakata K., et al. Regulation of a DLK-1 and p38 MAP kinase pathway by the ubiquitin ligase RPM-1 is required for presynaptic development. Cell 2005, 120:407-420.
52. Hendricks M., Jesuthasan S. PHR regulates growth cone pausing at intermediate targets through microtubule disassembly. J. Neurosci. 2009, 29:6593-6598.
53. Akhmanova A., Steinmetz M.O. Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat. Rev. Mol. Cell Biol. 2008, 9:309-322.
54. Galjart N. Plus-end-tracking proteins and their interactions at microtubule ends. Curr. Biol. 2010, 20:R528-R537.
55. Zhou F.Q., et al. NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 2004, 42:897-912.
56. Neukirchen D., Bradke F. Cytoplasmic linker proteins regulate neuronal polarization through microtubule and growth cone dynamics. J. Neurosci. 2011, 31:1528-1538.
57. Hur E.M., et al. GSK3 controls axon growth via CLASP-mediated regulation of growth cone microtubules. Genes Dev. 2011, 25:1968-1981.
58. Kumar P., et al. GSK3beta phosphorylation modulates CLASP-microtubule association and lamella microtubule attachment. J. Cell Biol. 2009, 184:895-908.
59. Wu X., et al. Skin stem cells orchestrate directional migration by regulating microtubule-ACF7 connections through GSK3beta. Cell 2011, 144:341-352.
60. Lin S., et al. Inhibition of Kinesin-5, a microtubule-based motor protein, as a strategy for enhancing regeneration of adult axons. Traffic 2011, 12:269-286.
61. Myers K.A., Baas P.W. Kinesin-5 regulates the growth of the axon by acting as a brake on its microtubule array. J. Cell Biol. 2007, 178:1081-1091.
62. Nadar V.C., et al. Kinesin-5 is essential for growth-cone turning. Curr. Biol. 2008, 18:1972-1977.
63. Usher L.C., et al. A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration. J. Neurosci. 2010, 30:4693-4706.
64. Chen L., et al. Axon regeneration pathways identified by systematic genetic screening in C. elegans. Neuron 2011, 71:1043-1057.
65. O'Rourke S.M., et al. Caenorhabditis elegans EFA-6 limits microtubule growth at the cell cortex. Nat. Cell Biol. 2010, 12:1235-1241.
66. Kazantsev A.G., Thompson L.M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 2008, 7:854-868.
67. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
68. Choudhary C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
69. Hubbert C., et al. HDAC6 is a microtubule-associated deacetylase. Nature 2002, 417:455-458.
70. Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem. J. 2007, 404:1-13.
71. Rivieccio M.A., et al. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19599-19604.
72. Janke C., Kneussel M. Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci. 2010, 33:362-372.
73. Matsuyama A., et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 2002, 21:6820-6831.
74. Zhang X., et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 2007, 27:197-213.
75. Erck C., et al. A vital role of tubulin-tyrosine-ligase for neuronal organization. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7853-7858.
76. Burnette D.T., et al. Filopodial actin bundles are not necessary for microtubule advance into the peripheral domain of Aplysia neuronal growth cones. Nat. Cell Biol. 2007, 9:1360-1369.
77. Medeiros N.A., et al. Myosin II functions in actin-bundle turnover in neuronal growth cones. Nat. Cell Biol. 2006, 8:215-226.
78. Schaefer A.W., et al. Filopodia and actin arcs guide the assembly and transport of two populations of microtubules with unique dynamic parameters in neuronal growth cones. J. Cell Biol. 2002, 158:139-152.
79. Neumann S., Woolf C.J. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron 1999, 23:83-91.
80. Brown M.E., Bridgman P.C. Myosin function in nervous and sensory systems. J. Neurobiol. 2004, 58:118-130.
81. Diefenbach T.J., et al. Myosin 1c and myosin IIB serve opposing roles in lamellipodial dynamics of the neuronal growth cone. J. Cell Biol. 2002, 158:1207-1217.
82. Vicente-Manzanares M., et al. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 2009, 10:778-790.
83. Christensen D.P., et al. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol. Med. 2011, 17:378-390.
84. Chuang D.M., et al. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 2009, 32:591-601.
85. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 2004, 29:95-102.
86. Minucci S., Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 2006, 6:38-51.
87. Rayasam G.V., et al. Glycogen synthase kinase 3: more than a namesake. Br. J. Pharmacol. 2009, 156:885-898.
88. Huszar D., et al. Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev. 2009, 28:197-208.
89. Canta A., et al. Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system. Curr. Med. Chem. 2009, 16:1315-1324.
90. Wang H., et al. Myosin II has distinct functions in PNS and CNS myelin sheath formation. J. Cell Biol. 2008, 182:1171-1184.
91. Camelo S., et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2005, 164:10-21.
92. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
93. Gabel C.V., et al. Distinct cellular and molecular mechanisms mediate initial axon development and adult-stage axon regeneration in C. elegans. Development 2008, 135:1129-1136.
94. Jiang H., et al. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 2005, 120:123-135.
95. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 2001, 280:720-725.
96. Kim W.Y., et al. Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth. Neuron 2006, 52:981-996.
97. Garrido J.J., et al. GSK3 alpha and GSK3 beta are necessary for axon formation. FEBS Lett. 2007, 581:1579-1586.
98. Shi S.H., et al. APC and GSK-3beta are involved in mPar3 targeting to the nascent axon and establishment of neuronal polarity. Curr. Biol. 2004, 14:2025-2032.
99. Tang M., et al. Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J. Neurosci. 2010, 30:9280-9291.
100. Haggarty S.J., et al. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4389-4394.
101. Tapia M., et al. Impaired function of HDAC6 slows down axonal growth and interferes with axon initial segment development. PLoS ONE 2010, 5:e12908.
102. Kozikowski A.P., et al. Functional differences in epigenetic modulators - superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies. J. Med. Chem. 2007, 50:3054-3061.
103. Butler K.V., et al. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J. Am. Chem. Soc. 2010, 132:10842-10846.
104. Finnin M.S., et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999, 401:188-193.
105. Gaub P., et al. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ. 2010, 17:1392-1408.
106. Luthi-Carter R., et al. SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7927-7932.
107. Outeiro T.F., et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 2007, 317:516-519.
108. Falnikar A., et al. Kinesin-5, a mitotic microtubule-associated motor protein, modulates neuronal migration. Mol. Biol. Cell 2011, 22:1561-1574.
109. Yan Y., et al. Inhibition of a mitotic motor protein: where, how, and conformational consequences. J. Mol. Biol. 2004, 335:547-554.
110. Brier S., et al. Identification of the protein binding region of S-trityl-l-cysteine, a new potent inhibitor of the mitotic kinesin Eg5. Biochemistry 2004, 43:13072-13082.
111. Luo L., et al. ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism. Nat. Chem. Biol. 2007, 3:722-726.
112. Brown J.A., et al. Dorsal root ganglion neurons react to semaphorin 3A application through a biphasic response that requires multiple myosin II isoforms. Mol. Biol. Cell 2009, 20:1167-1179.
113. Gallo G. RhoA-kinase coordinates F-actin organization and myosin II activity during semaphorin-3A-induced axon retraction. J. Cell Sci. 2006, 119:3413-3423.
114. Solecki D.J., et al. Myosin II motors and F-actin dynamics drive the coordinated movement of the centrosome and soma during CNS glial-guided neuronal migration. Neuron 2009, 63:63-80.
115. Ostap E.M. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor. J. Muscle Res. Cell Motil. 2002, 23:305-308.
116. Poulain F.E., Sobel A. The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players. Mol. Cell. Neurosci. 2010, 43:15-32.
117. Blesch A., Tuszynski M.H. Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci. 2009, 32:41-47.